Montreal, Canada, April, 8, 2013 - MethylGene Inc. today announced that preclinical data for the kinase inhibitor MG516 was presented at the American Association for Cancer Research Annual Meeting held in Washington DC.
http://www.biospace.com/news_story.aspx?StoryID=292718&full=1
http://www.biospace.com/news_story.aspx?StoryID=292718&full=1
